Lanean...

Breakthroughs in immune checkpoint therapy: overcoming NSCLC immune checkpoint therapy resistance with novel techniques

Immune checkpoint therapy has emerged as a revolutionary approach in the field of non-small cell lung cancer (NSCLC), offering new hope to patients with various malignancies. Despite its success, a significant proportion of patients exhibit primary or acquired resistance, limiting the efficacy of th...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Li-Ping Kang, Hua-Jing Huang, Cong Xu, Hui-Hui Chen, Dong-Hui Huang, Ze-Bo Jiang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2025-09-01
Saila:Frontiers in Immunology
Gaiak:
Sarrera elektronikoa:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1630940/full
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!